These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 3196570)
21. [Thermal energy balance during hemodialysis: the role of the filter membrane]. Panzetta G; Bianco F; Galli G; Ianche M; Savoldi S; Vianello S; Vidi E; Cicinato P G Ital Nefrol; 2002; 19(4):425-31. PubMed ID: 12369045 [TBL] [Abstract][Full Text] [Related]
22. In vivo evaluation of cellular and inflammatory response to a new polyethersulfone membrane. Stefoni S; Coli L; Cianciolo G; Donati G; Dalmastri V; Orlandi V; D'Addio F; Ramazzotti E Contrib Nephrol; 2003; (138):68-79. PubMed ID: 12463148 [No Abstract] [Full Text] [Related]
23. Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients. Wanner C; Bahner U; Mattern R; Lang D; Passlick-Deetjen J Nephrol Dial Transplant; 2004 Oct; 19(10):2570-5. PubMed ID: 15280524 [TBL] [Abstract][Full Text] [Related]
24. Phagocyte metabolic activity during hemodialysis with different dialyzers not affecting the number of circulating phagocytes. Vanholder R; Van Landschoot N; Waterloos MA; Delanghe J; Van Maele G; Ringoir S Int J Artif Organs; 1992 Feb; 15(2):89-92. PubMed ID: 1555881 [TBL] [Abstract][Full Text] [Related]
26. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications. Kadiri S; Kehinde Z; Arije A; Salako BL Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127 [TBL] [Abstract][Full Text] [Related]
27. Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Ronco C; Brendolan A; Lupi A; Metry G; Levin NW Kidney Int; 2000 Aug; 58(2):809-17. PubMed ID: 10916106 [TBL] [Abstract][Full Text] [Related]
28. [Efficiency of high-flow dialyzers in removal of beta-2-microglobulin]. Leto E; Bilal F; Osmic I Med Arh; 2001; 55(4):225-6. PubMed ID: 11769451 [TBL] [Abstract][Full Text] [Related]
29. Biocompatibility of hemodialysis membranes: evaluation in an ovine model. Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041 [TBL] [Abstract][Full Text] [Related]
30. Biocompatibility study on cuprophane and polysulphone dialysers. Taraba I; Polner K; Makó J Nephrol Dial Transplant; 1991; 6 Suppl 3():22-5. PubMed ID: 1775261 [No Abstract] [Full Text] [Related]
31. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration. Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678 [TBL] [Abstract][Full Text] [Related]
32. In vitro performance of hemodialysis membranes after repeated processing. Johnson A; Mishkin GJ; Lew SQ; Mishkin M; Abramson F; Lecchi P Am J Kidney Dis; 2003 Sep; 42(3):561-6. PubMed ID: 12955685 [TBL] [Abstract][Full Text] [Related]
33. Acute symptoms during and between hemodialysis: the relative role of speed, duration, and biocompatibility of dialysis. Skroeder NR; Jacobson SH; Lins LE; Kjellstrand CM Artif Organs; 1994 Dec; 18(12):880-7. PubMed ID: 7887824 [TBL] [Abstract][Full Text] [Related]
34. Permeability for middle and higher molecular weight substances. Comparison between polysulfone and cuprophan dialyzers. Brunner H; Mann H; Stiller S; Sieberth HG Contrib Nephrol; 1985; 46():33-42. PubMed ID: 4006479 [No Abstract] [Full Text] [Related]
35. Effects of a polyelectrolyte additive on the selective dialysis membrane permeability for low-molecular-weight proteins. Krieter DH; Morgenroth A; Barasinski A; Lemke HD; Schuster O; von Harten B; Wanner C Nephrol Dial Transplant; 2007 Feb; 22(2):491-9. PubMed ID: 17050637 [TBL] [Abstract][Full Text] [Related]
36. Biocompatibility aspects of dialyzer reprocessing: a comparison of 3 re-use methods and 3 membranes. Kuwahara T; Markert M; Wauters JP Clin Nephrol; 1989 Sep; 32(3):139-43. PubMed ID: 2791365 [TBL] [Abstract][Full Text] [Related]
37. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study. Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097 [TBL] [Abstract][Full Text] [Related]
38. [Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-flux helixone dialyzers]. Sobaszek-Pitas M; Kopeć J; Krzanowski M; Sułowicz W Przegl Lek; 2014; 71(7):384-8. PubMed ID: 25338334 [TBL] [Abstract][Full Text] [Related]
39. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients. Zehnder C; Gutzwiller JP; Renggli K Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310 [TBL] [Abstract][Full Text] [Related]
40. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]